Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Similar documents
Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Disclosures. Triptans for Kids 5/16/13

Faculty Disclosures. Learning Objectives

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

Management of headache

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor

Update on Diagnosis and Management of Migraines

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

How do we treat migraine? New SIGN Guidelines

Migraine Acute treatment

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Migraine much more than just a headache

Drug Class Review Triptans

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

Drug Class Review Triptans

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Drug List. Improving Outcomes in Episodic Migraine. Learning Objectives

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

Triptans Quantity Limit Program Summary

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Acute Migraine Treatment in Adults

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Manging Migraine in Children & Adults

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Faculty/Presenter Disclosure

Migraine. What are the symptoms of a migraine attack?

Faculty Disclosures. Learning Objectives

Chronic Daily Headaches

...SELECTED ABSTRACTS...

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

SIGN on the pharmacological management of migraine

Disclosures. Learning Objectives. Treatment Of Menstrual Migraine 11/10/2017. Research grants Aralez, Allergan

Headache A Practical Approach

ONZETRA XSAIL (sumatriptan) nasal powder

UPDATE IN MIGRAINE MANAGEMENT

THE WOMAN WHO COULD NOT DECIDE WHICH MEDICATION TO TAKE

Treatment of Primary Headache Syndromes

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

Treatment of Headache in the ED

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

4/12/2018. ECHO Ontario Chronic Pain Migraine. Migraine Definition and Epidemiology. Migraine - Undertreatment. Migraine - Diagnostic Classification

Clinical Learning Days November 10, 2017

Diclofenac potassium for oral solution (CAMBIA ) in the acute management of a migraine attack: clinical evidence and practical experience

Drug List. Improving Outcomes in Episodic Migraine. Presenter Disclosure Information. Learning Objectives. Improving Outcomes in Episodic Migraine

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial

Medication overuse headache is a severe chronic pain condition that is preventable and treatable. An International Experience

Daniel Kassicieh, DO, FAAN

Headaches in the Pediatric Emergency Dept

A new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Acute Migraine Treatment. Morris Levin, MD Professor of Neurology Director, Headache Center UCSF Department of Neurology San Francisco, CA

ADVANCES IN MIGRAINE MANAGEMENT

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Treatments for migraine

Controversies in Migraine Management

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Migrainous headache, the menstrual cycle and pregnancy. Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

Promius Pharma, a subsidiary of Dr. Reddy s Laboratories, Princeton, NJ; 2 Vedanta Research, Chapel Hill, NC; 3

Outpatient Headache Care Guideline

Headache. Section 1. Migraine headache. Clinical presentation

ISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc.

Dubai Standards of Care (Migraine)

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Drug Class Review on Triptans

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

MIGRAINE A MYSTERY HEADACHE

Optimizing triptan therapy in clinical practice

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain

Program Committee Disclosures

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Headache Questionnaire

Reviews/Evaluations. Medication-Overuse Headache

Pharmacy Medical Necessity Guidelines: Migraine Medications

Drug Class Review on the Triptans

Disclosures. Objectives 6/2/2017

Concerned. Surgery? About Pain After. Talk to Your Doctor About Reducing Postsurgical Pain

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Adolescent Migraine Treatment O F A

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Transcription:

WWW.AMERICANHEADACHESOCIETY.ORG Acute Treatment Strategies Content developed by: Lawrence C. Newman, MD, FAHS Donna Gutterman, PharmD Faculty Disclosures LAWRENCE C. NEWMAN, MD, FAHS Dr. Newman has received consulting fees and/or honoraria from Allergan, Inc., Labrys Biologics, NuPathe, and Zogenix. Dr. Newman is on the speaker bureaus for Allergan, Inc. and Zogenix. DONNA GUTTERMAN, PHARMD Dr. Gutterman has received consulting fees and/or honoraria from NuPathe, Teva Pharmaceuticals, Dr. Reddy Pharmaceuticals. Learning Objectives At the conclusion of this presentation, participants should be better able to: Identify comorbidities and exacerbating factors that might render acute therapies less efficacious Use MIDAS to assess the severity and impact of headache upon the patient Employ mtoq to assesses if acute therapies need to be modified Design a treatment plan that is stratified to the individual patient s treatment needs 1

Clinical Case Review: Carol Carol 2013, Age 32 1994 3-month history of headaches on Day -1 of menses Recommended APAP initially effective 2 headache days/month; nausea and photophobia Attacks 8 hours Unilateral (R>L) pain Ibuprofen 400 mg/day, 2x/month 1998 2012 10 14 headache days/month; nausea and photophobia Yawning, chocolate craving; attacks 8 20 hours Ibuprofen 8 days/month; oral triptan 4 days/month Depression, anxiety, low back pain 10 severe headache days/month 12 less severe headache days/month Nausea and photophobia (most marked with severe) Ibuprofen daily (both back pain and HA); oral triptan 4 days/month; Fioricet 20 days/month (multiple meds per day) Divorce Acute Treatment ARS Question 1 Which of the following historical features should influence your acute treatment recommendations for Carol? A. Allodynia B. Nausea C. Depression D. A and B E. All of the above 2

Assess Disability and Attack Characteristics MIDAS score = 84 (very severe disability) Diary may uncover triggers and under-reported headache attacks Nausea may influence treatment MIDAS, nausea, allodynia, photo Depression, pain, anxiety Migraine without Aura Review Prior Treatments, Unmet Needs, and Treatment Goals 95% of migraineurs use acute treatment (Rx or OTC) Acute therapy decisions often involve switching treatment Poor treatment response often leads to initial/follow-up consultations Understanding unmet needs is key to improving treatment Lipton et al. Cephalalgia. 2009:29:751 759. The Migraine Treatment Optimization Questionnaire (M-TOQ) Domain Functional response Consistency and onset Recurrence Questions Are you able to quickly return to your normal activities after taking your migraine medication? Can you count on your migraine medication to relieve your pain within 2 hours for most attacks? Dose one dose of your migraine medication usually relieve your headache and keep it away for at least 24 hours? Carol s responses Side effects Is your migraine medication well-tolerated? Yes Global Helps clinicians determine which treatment needs are met and which are unmet Are you comfortable enough to be able to plan your daily activities? Lipton et al. Cephalalgia. 2009:29:751 759. 3

Carol s Prior Treatments, Unmet Needs, and Treatment Goals Prior treatments OTC: acetaminophen, ibuprofen Prescription: oral triptan, Fioricet Unmet needs Functional response Rapid, consistent relief Low recurrence Treatment goals Relieve pain Restore function Rapid, consistent relief Formulate a Treatment Plan Carol s Acute Treatment Plan Should account for: Initial treatment Second-line treatment Rescue medication Consider: Triptan for very severe disability (MIDAS=84) n-oral treatment for frequent nausea 4

Formulating an Acute Treatment Plan B. Same drug, switch routes C. Switch drugs 1. Within class 2. Among classes D. Rationale polypharmacy/companion therapy E. Address secondary treatment and rescue F. Other modalities Formulating an Acute Treatment Plan Treat early with primary medication Improves onset and consistency of response Prevents disability and recurrence Reduces need for rescue May reduce risk of allodynia Optimize the dose for inconsistent response Provide advice on secondary treatment and rescue Secondary: recurrence Rescue: treatment failure Caution: Guard against overuse Formulating an Acute Treatment Plan B. Same drug, switch routes C. Switch drugs 1. Within class 2. Among classes D. Rationale polypharmacy/companion therapy E. Address secondary treatment and rescue F. Other modalities 5

Formulating an Acute Treatment Plan B. Same drug, switch routes Optimize the route of administration for patients with: Prominent nausea Vomiting Gastroparesis Crash migraine Consider non-oral therapy AM migraine Injections Nasal spray Suppository Inhaler Patch When Allodynia and Nausea are Present May need treatments with a faster onset Circumvent the gut to minimize gastroparesis Injectables Nasal sprays (some) Suppositories Iontophoretic patches Oral inhalers When Allodynia and Nausea are Present Treating Early Optimize benefits Minimize risk of MOH 6

Strategies Once on Triptans B. Same drug, switch routes C. Switch drugs 1. Within class: triptans o Onset: rizatriptan or eletriptan o Recurrence: eletriptan or almotriptan o Tolerability: naratriptan or almotriptan 2. Among classes o Failure of two or more trials of triptans o Consider other acute treatments DHE, lidocaine nasal spray, dopamine blockers, fast NSAIDs Addressing Unmet Needs: Acute Treatment Strategies B. Same drug, switch routes C. Switch drugs 1. Within class 2. Among classes D. Rationale polypharmacy/companion therapy E. Address secondary treatment and rescue F. Other modalities Choosing Acute Treatment Primary acute Secondary acute Rescue First-line treatment, usually early in the attack Recurrence after an initial response Lack of response to primary or secondary treatment Consider: Severity and degree of disability (stratified care) Age of headache onset Presence of nausea, vomiting, or gastroparesis Prior pattern of response Patient preference 7

Algorithm for Acute Treatment Primary Treatment Response? Yes Recurrence? Yes Treatment of Recurrence Response? Rescue Treatment Yes Good outcome Treatment Efficacy within the Class Primary Acute Treatment Secondary Acute Treatment Rescue Simple OTCs Yes Yes Rx NSAIDs Yes Yes Ketorolac (parenteral) Combination Analgesics Rarely Rarely Rarely Triptans Yes Yes Yes DHE Yes Yes Yes Lidocaine NS Yes Yes Yes Muscle relaxant Yes DA blockers Yes Yes Yes Corticosteroid Yes Opioids Rarely Addressing Unmet Needs: Acute Treatment Strategies for Carol B. Same drug, switch routes C. Switch the drug within the class 1. Optimize the agent within a class: ibuprofen o Onset: Already using prescription doses of ibuprofen (injectable ketoprofen, diclofenac oral solution) o Recurrence: Long half-life NSAIDs o Tolerability: Selective COX-2s 2. Switch class o From NSAIDs to triptans o Consider non-oral treatments 8

Primary Treatment: sumatriptan 100 mg po (early, no nausea) sumatriptan 6 mg sc (nausea or at least moderate pain) Acute Treatment ARS Question 2 What would you give for treatment of recurrence (ie, after sumatriptan 100 mg po)? A. Oral nonsteroidals B. Injectable nonsteroidals (ketorolac) C. Prochlorperazine (neuroleptic suppositories) D. A long-acting triptan (naratriptan or frovatriptan) E. Oral nsaid or repeat triptan Treatment of Recurrence: Repeat effective triptan OR naproxen 500mg (2 tablets) 9

Case Review: Acute Treatment Plan for Carol Primary Treatment Carol was diagnosed with episodic migraine without aura 100mg sumatriptan po 6 mg sumatriptan sc Secondary Treatment naproxen 500mg (2 tablets) Rescue Treatment prochlorperazine suppository What next? Case Review: Acute Treatment Plan for Carol Patient education Instructed Carol to: Treat early in the attack Keep headache and trigger diary Try relaxation technique Yoga Massage to reduce stress Encouraged to seek therapy for anxiety and depression Follow-up in 12 weeks Case Review: Follow-up Plan for Carol Carol returned to the clinic 15 weeks later Headache frequency was about the same Treatments were really working 10

Case Review: Follow-up Plan for Carol Carol returned to the clinic 15 weeks later Headache frequency was about the same Treatments were really working Primary Treatment: 100 mg sumatriptan po or 6 mg SC Oral works best taken early Oral does not work if nausea is prominent SC first-line for prominent nausea moderate severe pain Case Review: Follow-up Plan for Carol Carol returned to the clinic 15 weeks later Headache frequency was about the same Treatments were really working Secondary Treatment: Repeat triptan, offer naproxen 500mg (2 tablets) Recurrence occurs about 30% of the time Repeated triptan 80%; naproxen success 50% Much preferred over the rescue choice Case Review: Follow-up Plan for Carol Carol returned to the clinic 15 weeks later Headache frequency was about the same Treatments were really working Rescue Treatment: prochlorperazine suppository Needed twice Caused akathisia Instructed to use diphenhydramine (which had not been used) before using prochlorperazine suppositories 11

Case Review: Follow-up Plan for Carol Provided refills of her prescriptions Instructed to: Limit naproxen to 2 doses/week Seek counseling for depression and anxiety 3 recommendations provided Encouraged to come to monthly support groups at clinic for female headache patients Complete a daily headache diary Follow-up 12 weeks Case Review: Follow-up Plan for Carol As we know...carol was lost to follow-up after this Summary: Key Steps to Successful Acute Treatment 12

WWW.AMERICANHEADACHESOCIETY.ORG 13